DEFERASIROX

Product NDC
59651-449
11-digit product format
596510449
Labeler code
59651
Product ID
59651-449_c220484e-1e6a-4a0c-a221-60223f3bc24c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DEFERASIROX
Dosage form
GRANULE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA215137
Marketing category
ANDA
Marketing start
2025-09-08
Substance
DEFERASIROX
Active strength
360 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215137-001DEFERASIROXDEFERASIROX90MGGRANULE / ORALAB2025-09-08
A215137-002DEFERASIROXDEFERASIROX180MGGRANULE / ORALAB2025-09-08
A215137-003DEFERASIROXDEFERASIROX360MGGRANULE / ORALAB2025-09-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A215137-001AB
A215137-002AB
A215137-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A215137-001DEFERASIROX90MGGRANULE / ORALAB2025-09-08011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215137-002DEFERASIROX180MGGRANULE / ORALAB2025-09-08011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215137-003DEFERASIROX360MGGRANULE / ORALAB2025-09-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-001DEFERASIROX90MGGRANULE / ORALAB2025-09-0831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-002DEFERASIROX180MGGRANULE / ORALAB2025-09-0831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-003DEFERASIROX360MGGRANULE / ORALAB2025-09-0831067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-001DEFERASIROX90MGGRANULE / ORALAB2025-09-08a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-002DEFERASIROX180MGGRANULE / ORALAB2025-09-08a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-003DEFERASIROX360MGGRANULE / ORALAB2025-09-08a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A215137-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215137-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215137-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215137-003AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215137-003AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
DEFERASIROX
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DEFERASIROX360 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
V8G4MOF2V9Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1923822Internal RxNorm lookup
1923826Internal RxNorm lookup
1923828Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
c220484e-1e6a-4a0c-a221-60223f3bc24cAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1e1ec29c-8ce7-9963-3c87-cf7d9cd3b139Product name520250624
0feb0248-301d-406d-9b41-7d80ddbec8a8Product name420201216

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59651-449-30DEFERASIROX30 in 1 CARTONGRANULE301
59651-449-54DEFERASIROX1 in 1 PACKETGRANULE11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59651-449-30EA - Each59651-449147c06be-612a-41c4-9f7f-48b67a43de1c12026-01-08
59651-449-54EA - Each59651-449eefbbbde-037e-4dc3-b67c-83f009b8a2ee12026-01-08

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DEFERASIROXDEFERASIROXAurobindo Pharma Limitedc220484e-1e6a-4a0c-a221-60223f3bc24c2025-09-09Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215137
application number: ANDA215137
ndc (product): 59651-449

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1923828deferasirox 180 MG Oral GranulesPSNc220484e-1e6a-4a0c-a221-60223f3bc24c1
1923826deferasirox 360 MG Oral GranulesPSNc220484e-1e6a-4a0c-a221-60223f3bc24c1
1923822deferasirox 90 MG Oral GranulesPSNc220484e-1e6a-4a0c-a221-60223f3bc24c1
1923828deferasirox 180 MG Oral GranulesSCDc220484e-1e6a-4a0c-a221-60223f3bc24c1
1923826deferasirox 360 MG Oral GranulesSCDc220484e-1e6a-4a0c-a221-60223f3bc24c1
1923822deferasirox 90 MG Oral GranulesSCDc220484e-1e6a-4a0c-a221-60223f3bc24c1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
59651-449-305965104493030 PACKET in 1 CARTON (59651-449-30) / 1 GRANULE in 1 PACKET (59651-449-54) 30 packet2025-09-08NoNoCurrent
59651-449-54596510449541 in 1 PACKETHistorical